What If We Could Catch Disease Earlier, Before Symptoms Start?
Buck Institute advocates for a shift toward monitoring early biological changes and biomarkers to detect disease before symptoms, promoting longitudinal, multi‑omic and digital approaches to enable pre-symptomatic intervention and research.
Why it mattersBuck Institute recommends routine biomarker surveillance, so health systems should fund early-disease assay development.